Joseph Yang, PharmD, MS

Boehringer Ingelheim

Poster(s):

• (346) Real-world healthcare resource utilization and economic burden associated with idiopathic pulmonary fibrosis in commercially insured and Medicare Advantage Populations in the United States
  Wednesday, October 29, 2025

• (348) Real-world healthcare resource utilization and economic burden associated with progressive pulmonary fibrosis in commercially insured and Medicare Advantage Populations in the United States
  Wednesday, October 29, 2025

• (375) Socioeconomic disparities in healthcare resource utilization and costs among Medicare Fee-for-Service beneficiaries with progressive pulmonary fibrosis
  Wednesday, October 29, 2025